Research dossier
Clinical research on Vitamin A
9 trials reviewed across 6 indications.
Strongest evidence
Vision and prevention of blindness
Mechanism
Retinal in the form of 11-cis-retinal binds opsin in rod photoreceptors to form rhodopsin, the molecule responsible for low-light vision. Vitamin A is also required for the integrity of the corneal epithelium. Frank deficiency causes night blindness and progressive corneal damage that ends in xerophthalmia and blindness.
The most clearly established role for vitamin A. Repletion reverses night blindness in deficient individuals and prevents permanent corneal damage. Vitamin A deficiency remains a leading cause of preventable childhood blindness globally.
Profound benefit in deficient populations. Routine supplementation does not improve vision in already-replete adults.
Trials cited
Pooled evidence — vitamin A repletion for night blindness and xerophthalmia
positive · Systematic review
Pooled clinical evidence summarized in WHO and StatPearls vitamin A deficiency literatureVitamin A repletion reverses early night blindness and prevents progression to corneal scarring in deficient individuals. This is the gold-standard clinical use case for vitamin A — directly correcting a deficiency that causes preventable blindness in millions of children worldwide.
Treatment of frank deficiency, not supplementation in well-fed adults.
Immune function in deficient populations
Mechanism
Vitamin A is required for epithelial barrier integrity, T-cell differentiation, and antibody response. Deficiency impairs both innate and adaptive immunity, particularly mucosal defense.
Periodic high-dose vitamin A reduces all-cause child mortality by roughly 12% in deficient populations and roughly halves measles mortality. WHO recommends therapeutic vitamin A for all children with measles in deficient settings. The benefit in deficient populations is large and well-documented.
Benefit is concentrated in vitamin A-deficient populations. In well-fed countries, routine supplementation does not improve immune outcomes.
Cochrane review — vitamin A for child mortality in low-income settings
positive · Systematic review
Imdad et al., 2017, Cochrane Database of Systematic Reviews (PMID 28282701)n=1202382Cochrane review of 47 trials and over 1.2 million children. Periodic high-dose vitamin A reduced all-cause child mortality by roughly 12% in low-income settings where vitamin A deficiency is common. Particularly strong reductions in measles mortality and diarrheal disease.
Benefit is real and large in deficient populations. Does not generalize to children in well-fed countries where vitamin A deficiency is rare.
Sommer Indonesia trial — vitamin A and child mortality
positive · RCT
Sommer et al., 1986, Lancet (PMID 3277608)n=25939Foundational trial demonstrating that periodic high-dose vitamin A in deficient preschool children cut mortality by approximately 34%. Drove WHO and UNICEF policy on global vitamin A supplementation programs.
Population was vitamin A-deficient by design. The result is not extrapolable to well-fed children.
Pooled evidence — vitamin A and immune function in deficient populations
positive · Systematic review
Pooled WHO and Cochrane evidence on vitamin A in measles, diarrhea, and childhood infectionWHO recommends high-dose vitamin A for all children with measles in deficient populations. Pooled trials show roughly halved measles mortality and reduced complications. Similar evidence supports treatment-dose vitamin A in severe diarrheal disease.
Therapeutic, not preventive. Applied to acute illness in deficient children, not as a routine supplement in healthy people.
General health
Mechanism
Vitamin A supports growth, reproductive function, gene expression via retinoic acid receptors, and epithelial maintenance throughout the body.
Adequate vitamin A intake is necessary for normal physiology. Most people in well-fed countries get enough from food. Routine high-dose supplementation has no clear general-health benefit and at high enough doses causes liver damage, bone fragility, and birth defects.
Best obtained from food (liver, dairy, eggs, dark leafy greens, orange and yellow vegetables) rather than high-dose supplements.
Skin health
Mechanism
Topical and oral retinoids (synthetic vitamin A analogs) treat acne and photoaging via retinoic acid receptor activation. The rationale for oral vitamin A in cosmetic skin contexts borrows from this prescription pharmacology.
Topical retinoids are well-established in dermatology. Oral vitamin A supplementation for cosmetic skin benefit has minimal randomized evidence, and high oral doses produce systemic side effects long before any plausible cosmetic gain.
Use a topical retinoid for skin goals; do not chase oral high-dose vitamin A.
Pregnancy
Mechanism
Retinoic acid is a potent regulator of embryonic development. Excess preformed vitamin A in early pregnancy disrupts cranial neural crest migration, causing characteristic retinoid embryopathy.
Adequate vitamin A is needed in pregnancy, but high-dose preformed vitamin A above 10,000 IU/day in early pregnancy is teratogenic. Prenatal vitamins typically use beta-carotene rather than retinyl esters specifically to avoid this risk.
Pregnant women should not take supplemental preformed vitamin A above the prenatal vitamin allowance. Beta-carotene from food is safe.
Rothman — vitamin A in pregnancy and birth defects
negative · Observational
Rothman et al., 1995, NEJM (PMID 7477116)n=22748Prospective cohort showing that women consuming more than 10,000 IU/day of preformed vitamin A in early pregnancy had a sharply elevated rate of birth defects, particularly cranial-neural-crest defects. This converged with isotretinoin and etretinate teratogenicity data to lock in the pregnancy safety guidance.
Observational, but mechanistically consistent with the well-known retinoid teratogenicity literature. Beta-carotene from food is not implicated; the risk is preformed retinyl esters.
Cancer prevention
Mechanism
The antioxidant hypothesis suggested carotenoids would prevent oxidative DNA damage and cancer. The hypothesis failed in trials and the supplementation actively increased cancer in smokers.
Two large randomized trials (CARET, ATBC) showed supplemental beta-carotene increased lung cancer incidence in smokers. The Bjelakovic meta-analysis linked supplemental vitamin A to a 16% increase in all-cause mortality. Routine vitamin A or beta-carotene supplementation for cancer prevention is not just unsupported, it is contraindicated in smokers.
Smokers should not take supplemental beta-carotene under any circumstances. Routine vitamin A supplementation is not a cancer-prevention strategy.
CARET — beta-carotene and retinol in smokers and asbestos-exposed workers
negative · RCT
Omenn et al., 1996, NEJM (PMID 8602180)n=18314The trial that defined the harm risk. Over 18,000 current/former smokers and asbestos-exposed workers were given high-dose beta-carotene plus preformed vitamin A. The trial was stopped early because lung cancer rates rose 28% in the supplemented group, and total mortality rose 17%. The hypothesis that antioxidant carotenoids prevent lung cancer was decisively reversed.
Dose was high and population was high-risk. The harm signal in smokers has been replicated in ATBC. Not relevant to people who have never smoked, but a hard stop sign for any smoker considering beta-carotene.
ATBC — alpha-tocopherol and beta-carotene in male smokers
negative · RCT
ATBC Cancer Prevention Study Group, 1994, NEJM (PMID 8127329)n=29133Companion finding to CARET, published earlier. 29,000 Finnish male smokers given beta-carotene saw an 18% increase in lung cancer incidence and 8% higher total mortality vs placebo. The first major signal that supplemental beta-carotene worsens outcomes in heavy smokers.
Only male smokers; results in non-smokers cannot be inferred. The harm to smokers, however, is confirmed.
Bjelakovic antioxidant meta-analysis — mortality from supplemental antioxidants
negative · Meta-analysis
Bjelakovic et al., 2007, JAMA (PMID 17327526)n=232606Bayesian meta-analysis of 68 antioxidant supplementation trials. Vitamin A (alone or in combination) was associated with a 16% increase in all-cause mortality. Beta-carotene was associated with a 7% increase. The antioxidant cancer-prevention hypothesis collapsed in pooled data.
Trials were heterogeneous. The mortality signal for vitamin A and beta-carotene is consistent with the CARET and ATBC harm findings.
3 forms of Vitamin A compared
Retinyl palmitate
Well absorbed; preformed and active
Best forMost multivitamin and prescription vitamin A formulationsPreformed vitamin A. Body cannot regulate absorption — surplus accumulates in the liver and at high chronic intake causes hypervitaminosis A. The form linked to teratogenicity in pregnancy and the form used in CARET.
Retinyl acetate
Well absorbed; preformed and active
Best forOlder vitamin A formulations and pharmaceutical retinolFunctionally equivalent to retinyl palmitate. Same accumulation and teratogenicity considerations apply.
Beta-carotene
Provitamin A — body converts to retinol on demand. Conversion is regulated and inefficient at high intake, so toxicity is not a concern from food.
Best forPrenatal vitamins, antioxidant blends, food fortificationFrom orange and yellow plants. Body regulates conversion to vitamin A, so dietary excess does not cause hypervitaminosis A — but supplemental beta-carotene at the doses used in CARET and ATBC increased lung cancer in smokers. Smokers should avoid supplemental beta-carotene.
Are you deficient? Symptoms, risk groups, lab tests
Vitamin A deficiency is rare in well-fed countries — under 1% of US adults — but remains widespread in low- and middle-income countries where it affects approximately one-third of preschool-aged children and is a leading cause of preventable childhood blindness and infectious-disease mortality.
Common symptoms
- Night blindness — difficulty seeing in low light, the earliest symptom
- Dry eyes (xerophthalmia)
- Bitot's spots — foamy white patches on the conjunctiva
- Corneal ulcers and scarring in advanced deficiency
- Increased susceptibility to infections, particularly respiratory and diarrheal
- Dry, scaly skin (hyperkeratosis)
- Slower growth and developmental delay in children
- Anemia secondary to impaired iron mobilization
- Severe measles complications in deficient children
Who is at risk
Children in low-income countries with limited diet diversity
Diets dominated by polished rice, maize, or other staples low in retinol and provitamin A produce widespread deficiency. WHO supplementation programs target this population specifically.
Adults with fat malabsorption disorders
Vitamin A is fat-soluble. Cystic fibrosis, chronic pancreatitis, celiac disease, Crohn's, cholestatic liver disease, and bariatric surgery all impair absorption.
People with severe liver disease
The liver stores 50–80% of body vitamin A and synthesizes retinol-binding protein. Cirrhosis depletes both the reservoir and the transport capacity.
Premature infants
Limited prenatal vitamin A transfer plus low hepatic stores make premature newborns vulnerable to deficiency, particularly relevant in chronic lung disease of prematurity.
Strict plant-based eaters with limited orange/yellow produce intake
Plant foods contain only provitamin A carotenoids, not preformed retinol. Conversion is genetically variable — 20–45% of people are inefficient converters. Diets very low in carotene-rich produce can produce functional insufficiency.
Adults with chronic alcohol use
Alcohol impairs hepatic vitamin A storage and conversion. Notably, vitamin A toxicity also occurs at lower doses in heavy drinkers, so both ends of the dose-response shift.
Lab markers
Serum retinol
The standard test for vitamin A status. Reflects status only when liver stores are exhausted — early or moderate deficiency may not show on serum retinol. Acute infection lowers serum retinol independent of nutritional status.
Better:Retinol-binding protein, Modified relative dose response (research)
- Severe deficiency
- <0.35 µmol/L (<10 µg/dL)
- Marginal deficiency
- 0.35–0.7 µmol/L (10–20 µg/dL)
- Adequate
- >0.7 µmol/L (>20 µg/dL)
Side effects and drug interactions
Side effects
Birth defects from preformed vitamin A in pregnancy
Severe · Above 10,000 IU/day preformed vitamin A in pregnancy
Preformed vitamin A above 10,000 IU/day in early pregnancy causes characteristic retinoid embryopathy, including cranial neural crest defects, cardiac defects, and CNS malformations.
Worse with:retinyl palmitate, retinyl acetate
Increased lung cancer in smokers (beta-carotene)
Severe · 20 mg/day or higher in current or former heavy smokers
Supplemental beta-carotene at 20–30 mg/day increased lung cancer in smokers in both CARET and ATBC. Smokers should not take supplemental beta-carotene.
Worse with:beta-carotene
Hypervitaminosis A — chronic toxicity
Severe · Sustained intake above 10,000 IU/day in adults
Sustained high-dose preformed vitamin A causes liver damage, bone pain, hair loss, dry cracking lips, headaches, and increased intracranial pressure (pseudotumor cerebri).
Worse with:retinyl palmitate, retinyl acetate
Acute vitamin A toxicity
Uncommon
Single very large doses (over 200,000 IU in adults) can cause headache, nausea, vomiting, dizziness, and skin peeling. Resolves on stopping but uncomfortable.
Increased fracture risk at chronic high intake
Uncommon · Chronic intake above 5,000–10,000 IU/day
Population data and some intervention data link chronic high preformed vitamin A intake to lower bone density and elevated hip fracture risk in older adults.
Carotenemia
Common
Yellow-orange skin discoloration, particularly on palms and soles, from very high beta-carotene intake. Cosmetic only, reverses on stopping.
Worse with:beta-carotene
Drug interactions
Additive effect
isotretinoin (Accutane)acitretinbexaroteneall-trans retinoic acidPrescription retinoids are themselves vitamin A analogs. Combining with supplemental vitamin A produces additive retinoid toxicity.
Do not take supplemental vitamin A while on a prescription retinoid. The dermatologist will advise on dietary intake.
Additive effect
warfarinHigh-dose vitamin A can amplify warfarin's anticoagulant effect via mechanisms that are not fully characterized.
Avoid high-dose vitamin A while on warfarin without prescriber input.
Reduces nutrient status
orlistatbile acid sequestrants (cholestyramine, colestipol)mineral oilThese agents impair fat-soluble vitamin absorption.
Separate vitamin A dosing from these drugs by at least 2 hours.
Combined-effect risk
alcohol (chronic heavy use)Alcohol both depletes hepatic vitamin A stores and lowers the threshold for vitamin A hepatotoxicity.
Heavy drinkers should not take high-dose vitamin A — the liver injury threshold is lower than in non-drinkers.
Other critical caveats
- High-dose preformed vitamin A in pregnancy causes severe birth defects. Pregnant women should not take supplemental retinyl palmitate or retinyl acetate above the prenatal vitamin allowance. Beta-carotene from food is the preferred source in pregnancy.
- Smokers should not take supplemental beta-carotene. CARET and ATBC both showed increased lung cancer in smokers given supplemental beta-carotene at the doses sold over the counter. The harm signal is consistent and clinically meaningful.
- Chronic preformed vitamin A above 10,000 IU/day causes liver damage, bone fragility, and increased fracture risk. Prefer food sources or beta-carotene rather than high-dose retinyl ester supplements.
Frequently asked
Is it safe to take vitamin A every day?
At food-level doses, yes. The Recommended Dietary Allowance is 2,333 IU (700 µg RAE) for women and 3,000 IU (900 µg RAE) for men. The Tolerable Upper Intake Level is 10,000 IU/day for adults. Sustained intake above this causes liver damage and bone fragility. Most adults in well-fed countries get enough from diet and do not need a vitamin A supplement at all.Should I take vitamin A or beta-carotene?
If you supplement at all, beta-carotene is the safer choice for most non-smokers because the body regulates its conversion to active vitamin A. The major exception: smokers should NOT take supplemental beta-carotene. CARET and ATBC both showed increased lung cancer in smokers given supplemental beta-carotene. Pregnant women should also avoid high-dose preformed vitamin A — beta-carotene from food is preferred.Can I take vitamin A while pregnant?
Adequate vitamin A is needed in pregnancy, but supplemental preformed vitamin A above 10,000 IU/day in early pregnancy is teratogenic — it causes characteristic birth defects. Use a prenatal vitamin that delivers vitamin A as beta-carotene rather than retinyl palmitate, and do not take separate high-dose vitamin A supplements without obstetric guidance.Will vitamin A help my skin?
Topical retinoids work — that's prescription dermatology. Oral vitamin A supplementation for cosmetic skin benefit has minimal randomized evidence and the systemic side effects show up at doses well below any plausible cosmetic gain. Use a topical retinoid for skin goals; do not chase oral high-dose vitamin A.What should I do if I have vitamin A deficiency?
Treat under medical supervision. Frank deficiency with night blindness or eye changes warrants therapeutic dosing per WHO or local guidelines. Identify the underlying cause — most commonly fat malabsorption, chronic liver disease, or severely restricted diet — and address it. Untreated, deficiency progresses to permanent corneal damage and blindness.
References
- 01NIH Office of Dietary Supplements — Vitamin A and Carotenoids Health Professional Fact Sheet
- 02StatPearls — Vitamin A Deficiency (NCBI Bookshelf)
- 03StatPearls — Vitamin A Toxicity (NCBI Bookshelf)
Last reviewed2026-05-07